AlphaYouAD
Insider selling
Adam D. Levy sold $2K of Acrivon Therapeutics, Inc. (ACRV) stock
Adam D. Levy, Chief Financial Officer of Acrivon Therapeutics, Inc. (ACRV), sold 1,142 shares of ACRV stock worth $2K, per an SEC Form 4 filed Aug 6, 2026.
It was an open-market sale.
The trade happened on Aug 4, 2026, 2 days before it was made public.
ACRV has moved +37.8% since the trade date, from $1.56 to $2.15 (Sep 22, 2026 close).
- Traded
- Aug 4, 2026
- Disclosed
- Aug 6, 2026
- Filing delay
- 2 days
- Price since
- +37.8%
- Role
- Chief Financial Officer
- Source
- SEC Form 4
More ACRV insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.